ADAM8 and hepatocellular carcinoma: To establish a dose‐dependent role of different ADAM8 expression levels for HCC progression, ADAM8 expression was either reduced via shRNA‐ or siRNA‐mediated knockdown or increased by using a retroviral overexpression vector.